Efficacy of cetirizine in the treatment of seasonal allergic rhinoconjunctivitis.
The efficacy of cetirizine, 10 mg once daily, in the treatment of seasonal allergic rhinoconjunctivitis was evaluated in a double-blind placebo-controlled trial. Sixteen patients monosensitized to olive pollen were treated simultaneously for 6 weeks, including one pollen season. Severity of symptoms and rescue drug consumption were significantly lower in the cetirizine group.
Panayotopoulos
S M
SM
Third Department of Internal Papanicolaou State General Hospital, Aristotelian University of Thessaloniki, Greece.
Panayotopoulou
E S
ES
D000328:Adult; D017332:Cetirizine; D002986:Clinical Trials as Topic; D003233:Conjunctivitis, Allergic / Q000150:complications / Q000188:drug therapy*; D004311:Double-Blind Method; D006634:Histamine H1 Antagonists / Q000627:therapeutic use*; D006801:Humans; D006919:Hydroxyzine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D010919:Placebos; D006255:Rhinitis, Allergic, Seasonal / Q000150:complications / Q000188:drug therapy*
D006634:Histamine H1 Antagonists; D010919:Placebos; D006919:Hydroxyzine; D017332:Cetirizine